吃播视频干预在消化系统肿瘤患者化疗所致食欲减退中的应用:一项随机对照试验

注册号:

Registration number:

ChiCTR2600123962 

最近更新日期:

Date of Last Refreshed on:

2026-05-05 21:42:53 

注册时间:

Date of Registration:

2026-05-05 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

吃播视频干预在消化系统肿瘤患者化疗所致食欲减退中的应用:一项随机对照试验

Public title:

Application of Mukbang Video Intervention in Chemotherapy-Induced Anorexia in Patients with Digestive System Tumors: A Randomized Controlled Trial

注册题目简写:

English Acronym:

研究课题的正式科学名称:

吃播视频干预在消化系统肿瘤患者化疗所致食欲减退中的应用:一项随机对照试验

Scientific title:

Application of Mukbang Video Intervention in Chemotherapy-Induced Anorexia in Patients with Digestive System Tumors: A Randomized Controlled Trial

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

秦曦贤 

研究负责人:

刘玄 

Applicant:

Xixian Qin 

Study leader:

Xun Liu 

申请注册联系人电话:

Applicant telephone:

+86 13242085058

研究负责人电话:

Study leader's
telephone:

+86 755 8120151

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

qinxixian@sysush.com

研究负责人电子邮件:

Study leader's E-mail:

liuxuan@sysush.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

广东省深圳市光明区圳园路628号

研究负责人通讯地址:

广东省深圳市光明区圳园路628号

Applicant address:

No. 628, Zhenyuan Road, Guangming District, Shenzhen City, Guangdong Province

Study leader's address:

No. 628, Zhenyuan Road, Guangming District, Shenzhen City, Guangdong Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

中山大学附属第七医院(深圳)

Applicant's institution:

The Seventh Affiliated Hospital of Sun Yat-sen University (Shenzhen)

研究负责人所在单位:

中山大学附属第七医院

Affiliation of the Leader:

The Seventh Affiliated Hospital Sun Yat-sen University

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

KY-2026-026-01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

中山大学附属第七医院科研伦理委员会

Name of the ethic committee:

Ethics approval Certificate of the Medical Ethics Committee of the Seventh Affiliated Hospital, Sun Yat-sen University

伦理委员会批准日期:

Date of approved by ethic committee:

2026-02-06 00:00:00

伦理委员会联系人:

唐燕

Contact Name of the ethic committee:

Yan Tang

伦理委员会联系地址:

广东省深圳市光明区圳园路628号

Contact Address of the ethic committee:

No. 628, Zhenyuan Road, Guangming District, Shenzhen City, Guangdong Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 755 81207260

伦理委员会联系人邮箱:

Contact email of the ethic committee:

tangyan2@sysush.com

研究实施负责(组长)单位:

中山大学附属第七医院

Primary sponsor:

The Seventh Affiliated Hospital Sun Yat-sen University

研究实施负责(组长)单位地址:

广东省深圳市光明区圳园路628号

Primary sponsor's address:

No. 628, Zhenyuan Road, Guangming District, Shenzhen City, Guangdong Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东省

市(区县):

Country:

China

Province:

Guangdong

City:

单位(医院):

中山大学附属第七医院

具体地址:

广东省深圳市光明区圳园路628号

Institution
hospital:

The Seventh Affiliated Hospital of Sun Yat-sen University

Address:

No. 628, Zhenyuan Road, Guangming District, Shenzhen City, Guangdong Province

经费或物资来源:

中山大学附属肿瘤医院张力教授恶性肿瘤精准化诊治团队

Source(s) of funding:

Professor Li Zhang's Precision Oncology Team, Sun Yat-sen University Cancer Center

研究疾病:

消化系统恶性肿瘤  

Target disease:

Malignant tumors of the digestive system

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

本研究旨在通过随机对照试验,评估观看吃播视频这一干预措施对消化系统肿瘤化疗患者食欲的影响,探讨其作为非药物干预手段在临床支持治疗中的应用潜力,为改善消化系统肿瘤化疗患者食欲提供新思路。  

Objectives of Study:

This study aims to evaluate the effect of watching mukbang videos as an intervention on appetite in patients with digestive system tumors undergoing chemotherapy through a randomized controlled trial, explore its application potential as a non-pharmacological intervention in clinical supportive care, and provide new insights for improving appetite in this patient population.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1.存在严重消化道梗阻、吸收不良综合征等影响进食的疾病; 2.有严重视觉、听觉障碍,无法观看视频; 3.有精神疾病史或认知功能障碍,无法配合研究。

Exclusion criteria:

1. Presence of severe gastrointestinal obstruction, malabsorption syndrome, or other diseases affecting eating; 2. Severe visual or hearing impairment, unable to watch videos; 3. History of mental illness or cognitive dysfunction, unable to cooperate with the study.

研究实施时间:

Study execute time:

From 2026-05-05 00:00:00 To 2026-11-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-05-05 00:00:00 To 2026-08-05 00:00:00

干预措施:

Interventions:

组别:

干预组

样本量:

50

Group:

Intervention Group

Sample size:

干预措施:

吃播视频干预

干预措施代码:

Intervention:

Mukbang Video Intervention

Intervention code:

组别:

对照组

样本量:

50

Group:

Control Group

Sample size:

干预措施:

常规饮食护理

干预措施代码:

Intervention:

Routine Dietary Car

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东省 

市(区县):

 

Country:

China

Province:

Guangdong

City:

单位(医院):

中山大学附属第七医院 

单位级别:

三级甲等 

Institution
hospital:

The Seventh Affiliated Hospital of Sun Yat-sen University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

体重

指标类型:

主要指标

Outcome:

Body weight

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

体质指数

指标类型:

主要指标

Outcome:

Body mass index (BMI)

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

食欲视觉模拟评分

指标类型:

主要指标

Outcome:

Appetite visual analog scale (VAS) score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肿瘤患者食欲症状问卷评分

指标类型:

主要指标

Outcome:

Cancer Appetite Symptom Questionnaire (CASQ) score

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

24小时膳食回顾饮食量

指标类型:

主要指标

Outcome:

24-hour dietary recall intake

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

采用计算机生成的随机序列,以1:1的比例将患者分配至干预组或对照组。随机方案由独立统计师生成,并采用不透光的密封信封保存,以确保分配隐藏。

Randomization Procedure (please state who generates the random number sequence and by what method):

Patients were allocated to either the intervention group or the control group at a 1:1 ratio using a computer-generated randomization sequence. The randomization scheme was generated by an independent statistician and was maintained in opaque, sealed envelopes to ensure allocation concealment.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

开放标签

Blinding:

Open-label

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

www.medresman.org

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

www.medresman.org

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

通过纸质问卷收集数据,采用Excel软件录入数据,应用SPSS25.0软件进行数据分析

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data were collected using paper-based questionnaires, entered into Excel software, and analyzed using SPSS version 25.0 software.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2026-05-05 21:42:41